To further detect the role of RRS1 in breast cancer cells’ cisplatin resistance, we silenced the RRS1 gene using specific shRNA, which significantly decreased both mRNA and protein expression (Figure 2A–C). This evidence concerns the gene RRS1 and breast carcinoma.